Dr. John Strother
Claim this profileGood Samaritan Hospital
Area of expertise
Lung Cancer
John Strother has run 7 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
John Strother has run 5 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Good Samaritan Hospital
Clinical Trials John Strother is currently running
Osimertinib
for Non-Small Cell Lung Cancer
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting
1 award
Phase 2
42 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about John Strother
Clinical Trial Related
5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments John Strother has experience with
- Carboplatin
- Pembrolizumab
- Gemcitabine Hydrochloride
- Osimertinib
- Durvalumab
- Biospecimen Collection
Breakdown of trials John Strother has run
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Strother specialize in?
John Strother focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is John Strother currently recruiting for clinical trials?
Yes, John Strother is currently recruiting for 2 clinical trials in Corvallis Oregon. If you're interested in participating, you should apply.
Are there any treatments that John Strother has studied deeply?
Yes, John Strother has studied treatments such as Carboplatin, Pembrolizumab, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with John Strother?
Apply for one of the trials that John Strother is conducting.
What is the office address of John Strother?
The office of John Strother is located at: Good Samaritan Hospital, Corvallis, Oregon 97330 United States. This is the address for their practice at the Good Samaritan Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.